Država: Irska
Jezik: engleski
Izvor: HPRA (Health Products Regulatory Authority)
VANCOMYCIN HYDROCHLORIDE
Hikma Farmacêutica (Portugal) S.A.
J01XA; J01XA01
VANCOMYCIN HYDROCHLORIDE
500 milligram(s)
Powder for concentrate for solution for infusion
Product subject to prescription which may not be renewed (A)
Glycopeptide antibacterials; vancomycin
Not marketed
2013-01-04
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT VANCOMYCIN 500 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION VANCOMYCIN 1000 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION Vancomycin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Vancomycin is and what it is used for 2. What you need to know before you useVancomycin 3. How to use Vancomycin 4. Possible side effects 5. How to store Vancomycin 6. Contents of the pack and other information 1. WHAT VANCOMYCIN IS AND WHAT IT IS USED FOR Vancomycin is an antibiotic that belongs to a group of antibiotics called “glycopeptides”. Vancomycin works by eliminating certain bacteria that cause infections. Vancomycin powder is made into a solution for infusion. Vancomycin is used in in all age groups by infusion for the treatment of the following serious infections: • Infections of the skin and tissues below the skin. • Infections of bone and joints. • An infection of the lungs called "pneumonia". • Infection of the inside lining of the heart (endocarditis) and to prevent endocarditis in patients at risk when undergoing major surgical procedures 2. WHAT YOU NEED TO KNOW BEFORE YOU USE VANCOMYCIN DO NOT USE VANCOMYCIN - if you are allergic to vancomycin or any of the other ingredients of this medicine (listed in section 6). WARNING AND PRECAUTIONS Serious side effects that may lead to loss of vision have been reported following the injection of vancomycin in the eyes. Talk to your doctor or hospital pharmacist or nurse before using Vancomycin if: - Pročitajte cijeli dokument
Health Products Regulatory Authority 22 March 2024 CRN00F71V Page 1 of 14 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Vancomycin 500 mg Powder for concentrate for solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains: 500 mg vancomycin hydrochloride equivalent to 500,000 IU vancomycin. When reconstituted with 10 ml of water for injections, the resulting concentrate for solution for infusion contains 50 mg/ml vancomycin. For the full list of excipients, see 6.1. 3 PHARMACEUTICAL FORM Powder for concentrate for solution for infusion. Homogeneous, white to off-white freeze-dried powder. Reconstituted solution pH is 2.5 – 4.5. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Intravenous administration Vancomycin is indicated in all age groups for the treatment of the following infections (see sections 4.2, 4.4 and 5.1): - complicated skin and soft tissue infections (cSSTI) - bone and joint infections - community acquired pneumonia (CAP) - hospital acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP) - infective endocarditis Vancomycin is also indicated in all age groups for the perioperative antibacterial prophylaxis in patients that are at high risk of developing bacterial endocarditis when undergoing major surgical procedures. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Where appropriate, vancomycin should be administered in combination with other antibacterial agents. _Intravenous administration_ The initial dose should be based on total body weight. Subsequent dose adjustments should be based on serum concentrations to achieve targeted therapeutic concentrations. Renal function must be taken into consideration for subsequent doses and interval of administration _Patients aged 12 years and older_ The recommended dose is 15 to 20 mg/kg of body weight every 8 to 12 h (not to exceed 2 g per dose). In seriously ill patients, a loading do Pročitajte cijeli dokument